The U.S. Food and Drug Administration (FDA) has postponed a key meeting scheduled to determine the formula for the next set of COVID-19 vaccines amid a sudden spike in COVID cases linked to the ...
Delay due to 'administrative constraints' (Il Sole 24 Ore Radiocor) - New York, 10 May - US biotech group Moderna said the Food and Drug Administration had delayed approval of its vaccine for ...
(CNN) — The US Food and Drug Administration has approved another vaccine to help protect older people from respiratory syncytial virus, known as RSV. The shot, made by Moderna and sold under the ...
Welcome to 2024's regulatory tracker for Fierce Pharma. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new indications.
A group of licensed pharmacies providing drug compounding services challenged section 503A as an unconstitutional restriction of commercial free speech. On April 29, 2002, the Supreme Court found ...
Results that may be inaccessible to you are currently showing.